E. Podjarny et al., PREGNANCY-INDUCED HYPERTENSION IN RATS WITH ADRIAMYCIN NEPHROPATHY ISASSOCIATED WITH AN INADEQUATE PRODUCTION OF NITRIC-OXIDE, Hypertension, 29(4), 1997, pp. 986-991
Hypertensive complications are relatively common in pregnancy, particu
larly in the presence of preexisting renal disease. Although the patho
genesis of such complications is still unknown, recent animal studies
have suggested that it may be related to impaired synthesis of nitric
oxide (NO). Rats with adriamycin nephropathy develop a ''preeclamptic-
type'' pregnant state characterized by elevated blood pressure, lack o
f hyperfiltration, and enhanced proteinuria. Preliminary studies with
this model have implicated inadequate NO synthesis in the development
of preeclamptic-like pregnancy. The aim of the present study was to co
nfirm this hypothesis. Pregnant rats, both normal (PREG) and those wit
h adriamycin nephropathy (AN-PREG), received 100 mg/L N-omega-nitro-L-
arginine methyl ester PO from the middle of gestation to term (day 11,
term approximately 22 days). One group of AN-PREG rats received eithe
r L-arginine or D-arginine (2 g/L) from midpregnancy. At term, systoli
c pressure, mean arterial pressure, urinary metabolites of NO, creatin
ine clearance, and urinary protein were assessed. At term, compared wi
th virgin rats with adriamycin nephropathy, untreated AN-PREG rats had
increased systolic pressure, mean arterial pressure, and proteinuria
(mean arterial pressure, 124 +/- 2.5 versus 99.7 +/- 1.6 mm Hg [P<.05]
; proteinuria, 434 +/- 58 versus 216 +/- 63 mg/d [P<.05]). Creatinine
clearance did not change (1.68 +/- 0.23 versus 1.35 +/- 0.09 mL/min, P
=NS). In PREG rats, urinary metabolites of NO increased approximately
threefold at term pregnancy compared with control. By contrast, in AN-
PREG rats, excretion of urinary metabolites of NO increased only by ap
proximately 1.7-fold (P<.01) versus PREG rats. With the exception of A
N-PREG rats, inhibition of NO synthesis with N-omega-nitro-L-arginine
methyl ester enhanced blood pressure and decreased creatinine clearanc
e but did not influence proteinuria. Excretion of urinary metabolites
of NO Was similarly inhibited in all rats. In AN-PREG rats, L-arginine
normalized blood pressure (91 +/- 2.15 mm Hg) and lowered proteinuria
partially but significantly. D-Arginine had no effect. In summary, AN
-PREG rats are unable to adequately increase NO synthesis when physiol
ogically required. Correction of this deficit by L-arginine treatment
induced a significant clinical improvement.